Concepedia

Kathryn Mercer

KM

Statistics

Publications

5

Citations

443

H-Index

5

Active since

2002

Affiliations

University of Leicester(Current)

Institute of Cancer Research

Cancer Research UK

Kathryn Mercer is an author at University of Leicester specializing in oncogene activation, signal transduction, and signal transduction in cancer.

Publications per year

2002–2012

5

Publications

5

Expression of Endogenous Oncogenic<i>V600EB-raf</i>Induces Proliferation and Developmental Defects in Mice and Transformation of Primary Fibroblasts

Kathryn Mercer, Susan Giblett, Stuart A. Green et al. · Cancer Research · 2005 · 179 citations · Full text

, , +17

CRAF Autophosphorylation of Serine 621 Is Required to Prevent Its Proteasome-Mediated Degradation

Catherine Noble, Kathryn Mercer, Jahan Hussain et al. · Molecular Cell · 2008 · 101 citations · Full text

, , +14

The intermediate-activity<sup>L597V</sup>BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway

Catherine Andreadi, Lai-Kay Maggie Cheung, Susan Giblett et al. · Genes & Development · 2012 · 65 citations · Full text

, , +17

ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf

Kathryn Mercer, Antonio Chiloeches, Martin Hüser et al. · Oncogene · 2002 · 62 citations

, , +14

A-Raf and Raf-1 work together to influence transient ERK phosphorylation and Gl/S cell cycle progression

Kathryn Mercer, Susan Giblett, Anthony Oakden et al. · Oncogene · 2005 · 36 citations

, , +16

1–5 of 5